Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Clinical trial NCT03559517 · TERMINATED
Trial details
- NCT number
- NCT03559517
- Sponsor
- Shire
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2020-07-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.